跳至主要内容
临床试验/NCT06878924
NCT06878924尚未招募不适用

Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation

Texas Cardiac Arrhythmia Research Foundation0 个研究点目标入组 162 人开始时间: 2025年5月最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
162
主要终点
Recurrence of atrial arrhythmia: any episode of AF/AT longer than 30 sec off-AAD, after the 2-month blanking period

研究概览

简要总结

This study is designed to directly compare the safety and efficacy of PFA-based PVI+PWI vs PFA-based PVI+ VoM alcohol ablation in patients with Persistent AF.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic persistent AF; 1st or redo ablation with PVI-only in the earlier procedure
  • Willing to provide informed consent
  • Age: 18-85 years

排除标准

  • • Previous PWI or VoM ablation procedure
  • Left ventricular ejection fraction <40%
  • Left atrial thrombus
  • Myocardial infarction within last 60 days
  • Cardiac surgery in the last 6 months
  • Advanced renal failure
  • Life expectancy <1 year
  • Pregnant women
  • Unable or unwilling to provide informed consent

结局指标

主要结局

Recurrence of atrial arrhythmia: any episode of AF/AT longer than 30 sec off-AAD, after the 2-month blanking period

时间窗: 1 year

次要结局

  • • Arrhythmia-free on previously ineffective AAD without any dose-escalation(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Natale

Executive Medical Director

Texas Cardiac Arrhythmia Research Foundation

相似试验